Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors clinical trials

Explore recruiting pediatric patients with advanced ret altered solid or primary central nervous system tumors clinical trials.

Also recruiting in Europe

Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Study of the Oral RET Inhibitor LOXO-292 in Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors

Denmark, France, Germany, Spain, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors trials by city

Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Toronto Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Vancouver Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Montreal Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Calgary Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Edmonton Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Ottawa Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Winnipeg Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Quebec City Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Hamilton Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Kitchener Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in London Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Halifax Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in New York Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Los Angeles Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Chicago Pediatric Patients With Advanced Ret Altered Solid Or Primary Central Nervous System Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease